Profile data is unavailable for this security.
About the company
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.
- Revenue in JPY (TTM)152.99m
- Net income in JPY-7.44bn
- Incorporated1999
- Employees145.00
- LocationAnGes IncSaito Bio-Incubator, 7-7-15, Saito-AsagiIBARAKI-SHI 567-0085JapanJPN
- Phone+81 357302641
- Websitehttps://www.anges.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Veritas In Silico Inc | -100.00bn | -100.00bn | 7.69bn | 15.00 | -- | 3.26 | -- | -- | -- | -- | -- | 363.52 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 40.94 | -- | -- | -- | 101.54 | -- | 123.38 | -- | -- | -- |
Wakamoto Pharmaceutical Co Ltd | 7.98bn | -177.67m | 8.05bn | 292.00 | -- | 0.6852 | 34.60 | 1.01 | -5.12 | -5.12 | 229.89 | 337.15 | 0.525 | 2.08 | 2.88 | 27,324,600.00 | -1.17 | -2.58 | -1.34 | -3.00 | 46.98 | 53.08 | -2.23 | -4.33 | 3.45 | -- | 0.0085 | -- | 3.31 | -4.50 | -42.04 | 1.88 | -17.49 | 0.00 |
Kohjin Bio Co Ltd | -100.00bn | -100.00bn | 8.21bn | 157.00 | -- | 2.58 | -- | -- | -- | -- | -- | 634.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.15 | -- | 0.4102 | -- | 20.16 | -- | 41.20 | -- | -- | -- |
CanBas Co Ltd (Parent) | 0.00 | -1.07bn | 8.31bn | 12.00 | -- | 2.64 | -- | -- | -64.96 | -64.96 | 0.00 | 174.81 | 0.00 | -- | -- | 0.00 | -40.62 | -65.86 | -42.95 | -79.11 | -- | -- | -- | -1,094.10 | -- | -- | 0.00 | -- | -- | -- | -45.41 | -- | -- | -- |
Tsubota Laboratory Inc | 246.60m | -1.07bn | 9.21bn | 10.00 | -- | 8.74 | -- | 37.34 | -42.31 | -42.31 | 9.94 | 41.17 | 0.1023 | 2.20 | 29.16 | 24,660,200.00 | -44.25 | -- | -64.34 | -- | -182.07 | -- | -432.63 | -- | 1.92 | -417.04 | 0.1046 | -- | 48.96 | -- | -41.18 | -- | -- | -- |
TMS Co Ltd | 0.00 | -960.04m | 9.87bn | 14.00 | -- | 2.86 | -- | -- | -25.89 | -25.89 | 0.00 | 85.77 | 0.00 | -- | -- | -- | -26.14 | -- | -26.78 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -11.51 | -- | -- | -- |
Stella Pharma Corp | 254.09m | -765.17m | 10.18bn | 46.00 | -- | 3.81 | -- | 40.06 | -25.23 | -25.23 | 8.32 | 85.55 | 0.0637 | 0.0456 | 3.58 | 5,523,718.00 | -19.18 | -- | -20.37 | -- | 82.76 | -- | -301.14 | -- | 11.90 | -1,173.12 | 0.2671 | -- | 128.85 | -- | -1.45 | -- | -- | -- |
3-D Matrix Ltd | 3.74bn | -1.06bn | 10.21bn | 108.00 | -- | 16.14 | -- | 2.73 | -14.90 | -14.90 | 54.06 | 7.74 | 0.6653 | 0.4654 | 5.19 | 34,630,130.00 | -18.91 | -57.69 | -23.28 | -77.31 | 64.04 | 40.76 | -28.43 | -205.34 | 2.33 | -- | 0.8717 | -- | 53.63 | 58.87 | -29.09 | -- | -7.69 | -- |
Linical Co Ltd | 12.52bn | 680.40m | 10.24bn | 759.00 | 13.74 | 1.20 | 8.61 | 0.8181 | 30.12 | 30.12 | 554.28 | 346.38 | 0.7251 | -- | 3.99 | 16,494,230.00 | 3.94 | 4.71 | 6.55 | 7.23 | 33.10 | 31.60 | 5.43 | 5.98 | -- | 17,809.03 | 0.2793 | 45.36 | 8.32 | 6.55 | 27.06 | -4.97 | -33.01 | 4.94 |
AnGes Inc | 152.99m | -7.44bn | 10.67bn | 145.00 | -- | 0.3726 | -- | 69.72 | -39.40 | -39.40 | 0.8083 | 131.52 | 0.0045 | 0.1037 | 8.40 | 1,055,069.00 | -21.97 | -28.50 | -25.69 | -33.14 | 12.71 | 39.42 | -4,861.66 | -6,726.82 | 1.75 | -- | 0.0137 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
KOEI CHEMICAL COMPANY, LIMITED | 18.49bn | 62.58m | 11.10bn | 387.00 | 177.03 | 0.5104 | 3.77 | 0.6003 | 12.79 | 12.79 | 3,779.78 | 4,437.99 | 0.4599 | 1.30 | 4.51 | 47,770,930.00 | 0.1557 | 3.76 | 0.206 | 4.68 | 24.91 | 24.12 | 0.3385 | 6.66 | 0.5356 | 1.77 | 0.3089 | 35.80 | 7.55 | 0.4997 | -26.56 | -33.82 | 15.68 | 20.11 |
Medinet Co Ltd | 724.63m | -1.41bn | 11.54bn | 98.00 | -- | 1.97 | -- | 15.93 | -6.31 | -6.31 | 3.23 | 22.88 | 0.1224 | 11.93 | 3.61 | 7,394,143.00 | -23.74 | -21.05 | -24.75 | -22.47 | 17.72 | 28.75 | -193.90 | -135.40 | 19.58 | -- | 0.00 | -- | 4.40 | -7.90 | -14.66 | -- | -17.67 | -- |
ReproCell Inc | 2.51bn | -217.49m | 11.99bn | 92.00 | -- | 1.47 | -- | 4.78 | -2.56 | -2.56 | 29.48 | 90.90 | 0.3008 | 4.86 | 7.44 | 27,247,390.00 | -2.61 | -9.37 | -2.80 | -10.11 | 43.55 | 38.78 | -8.68 | -38.12 | 11.94 | -- | 0.00 | -- | 32.16 | 26.10 | 46.91 | -- | 28.24 | -- |
Nano Mrna Co Ltd | 164.39m | -1.05bn | 12.53bn | 17.00 | -- | 3.60 | -- | 76.22 | -14.94 | -14.94 | 2.34 | 49.40 | 0.0295 | 18.96 | 2.60 | 9,669,765.00 | -18.85 | -25.13 | -23.29 | -26.04 | 80.67 | 84.69 | -638.22 | -538.31 | 8.95 | -- | 0.2418 | -- | -23.42 | -4.84 | 30.33 | -- | -- | -- |
RaQualia Pharma Inc | 1.90bn | -323.66m | 12.94bn | 67.00 | -- | 2.11 | -- | 6.81 | -14.99 | -14.99 | 87.98 | 283.05 | 0.2896 | 3.13 | 3.15 | 28,376,150.00 | -4.93 | 2.13 | -5.29 | 2.26 | 87.11 | 88.49 | -17.02 | 5.32 | 12.35 | -- | 0.0567 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
Data as of May 10 2024. Currency figures normalised to AnGes Inc's reporting currency: Japanese Yen JPY
Holder | Shares | % Held |
---|---|---|
Simplex Asset Management Co., Ltd.as of 04 Apr 2024 | 968.70k | 0.48% |
SSgA Funds Management, Inc.as of 04 Apr 2024 | 109.70k | 0.06% |
Dimensional Fund Advisors LPas of 28 Mar 2024 | 80.10k | 0.04% |
SPARX Asset Management Co., Ltd.as of 10 Mar 2022 | 47.30k | 0.02% |
Dimensional Fund Advisors Ltd.as of 04 Apr 2024 | 25.59k | 0.01% |
BlackRock Investment Management (UK) Ltd.as of 31 Jul 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 09 May 2024Source: FactSet Research Systems Inc.